News Article
Josh Greenberg Speaks on Pharmaceutical Product-Liability Lawsuits
October 4, 2011
WASHINGTON, DC. – On October 4, Womble Carlyle attorney Josh Greenberg gave a webinar presentation for the Pharmaceutical Education & Research Institute on product-liability lawsuits against prescription drug manufacturers.
Greenberg discussed recent developments from across the nation on topics including:
- Putative class actions alleging purportedly misleading or off-label marketing;
- Recent preemption rulings involving failure-to-warn and design-defect claims against brand-name and generic drug manufacturers;
- The Supreme Court’s decision in Pliva, Inc. v. Mensing and its potential consequences, including the new tactics being used by plaintiffs’ lawyers and their allies; and
- Brand-name liability for generic drug warnings.
Josh Greenberg is a litigator with substantial experience in a diverse array of challenging cases, including product-liability and consumer-protection lawsuits by individuals, putative classes, and state attorneys general; judgment-enforcement and breach-of-contract actions involving real estate; a wide variety of constitutional and appellate matters; and white-collar prosecutions. Josh has particular experience defending pharmaceutical companies, especially prescription drug manufacturers, against claims alleging personal injuries, misleading marketing, and off-label promotion. He practices in Womble Carlyle’s Washington, D.C. office.